Kurzporträt
Mitarbeiterzahl: 70
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
James Robinson
CEO | Chief Executive Officer | 54 | 01.03.19 |
Ajay Bansal
DFI | Director of Finance/CFO | 62 | 28.10.19 |
Chief Tech/Sci/R&D Officer | 66 | - | |
Ryan Kubota
IRC | Investor Relations Contact | - | - |
Kenton Stewart
SAM | Sales & Marketing | - | 02.06.20 |
Nori Ebersole
HRO | Human Resources Officer | 60 | 01.12.17 |
Walt Johnston
PRN | Corporate Officer/Principal | - | 02.06.20 |
Christine Ocampo
AUD | Comptroller/Controller/Auditor | 51 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
James Hindman
BRD | Director/Board Member | 63 | 20.05.20 |
Sef P. Kurstjens
BRD | Director/Board Member | 60 | 01.07.18 |
James Robinson
CEO | Chief Executive Officer | 54 | 01.03.19 |
Director/Board Member | 59 | 27.12.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 32 743 396 | 5 633 501 ( 17,20 %) | 0 | 17,20 % |
Unternehmenskontakt
Urovant Sciences Ltd.
11-12 Saint James's Square Suite 1
SW1Y 4LB, London
+
Sektor
% 1. Jan. | Kap. | |
---|---|---|
-1.93% | 103 Mrd. | |
+0.41% | 95.71 Mrd. | |
+1.69% | 22.02 Mrd. | |
-17.38% | 20.9 Mrd. | |
-9.30% | 17.85 Mrd. | |
-41.01% | 16.21 Mrd. | |
-14.93% | 15.52 Mrd. | |
+3.46% | 13.86 Mrd. | |
+35.19% | 12.04 Mrd. |